Evidence map›Paper›PMID 38177903›Full record

ReviewEMBO reports2024

Inflammasomes as regulators of mechano-immunity.

Jelena S Bezbradica, Clare E Bryant

Open access · hybridAbstract readReview
In one paragraph

Review in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Mechanoepigenetics in musculoskeletal disease.Osteoarthritis and cartilage · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jelena S BezbradicaThe Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-1441-1727
Clare E BryantDepartment of Veterinary Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK. ceb27@cam.ac.uk.ORCID 0000-0002-2924-0038
University of Cambridge · GBUniversity of Oxford · GB

Funding

Kennedy Trust for Rheumatology Research (KTRR) KENN20 21 13Medical Research Council MR/W001217/1Medical Research Council MR/X000826/1UKRI | Medical Research Council (MRC) MR/W001217/1UKRI | MRC | Medical Research Foundation MR/X000826/1
6 · The paper itself

Abstract

Mechano-immunity, the intersection between cellular or tissue mechanics and immune cell function, is emerging as an important factor in many inflammatory diseases. Mechano-sensing defines how cells detect mechanical changes in their environment. Mechano-response defines how cells adapt to such changes, e.g. form synapses, signal or migrate. Inflammasomes are intracellular immune sensors that detect changes in tissue and cell homoeostasis during infection or injury. We and others recently found that mechano-sensing of tissue topology (swollen tissue), topography (presence and distribution of foreign solid implant) or biomechanics (stiffness), alters inflammasome activity. Once activated, inflammasomes induce the secretion of inflammatory cytokines, but also change cellular mechanical properties, which influence how cells move, change their shape, and interact with other cells. When overactive, inflammasomes lead to chronic inflammation. This clearly places inflammasomes as important players in mechano-immunity. Here, we discuss a model whereby inflammasomes integrate pathogen- and tissue-injury signals, with changes in tissue mechanics, to shape the downstream inflammatory responses and allow cell and tissue mechano-adaptation. We will review the emerging evidence that supports this model.

Indexed as

CytokinesInflammasomesHumansInflammationCytokinesInflammasomesForeign Body ReactionInflammasomesMacrophagesMechano-ResponsesMechano-Sensing

Identifiers

PMID38177903
PMCPMC10897344
OpenAlexW4389979959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.